EMA Releases HIV Treatment Guideline for Consultation - - BioPharm International

ADVERTISEMENT

EMA Releases HIV Treatment Guideline for Consultation


The European Medicines Agency (EMA) has released a draft revision of its guideline on the clinical development of medicines for the treatment of HIV infection, for a six-month public consultation. Comments are being accepted until March 31, 2014.

The proposed revision takes into account developments in HIV treatments that have occurred in the past few years, particularly the use of new, potent antiretroviral agents (ARTs). The guideline outlines a new definition of populations included in clinical trials, moving away from a focus on treatment history to an emphasis on documented viral resistance. Guidance is provided on the development programs and type of data that should be provided for new ARTs.

Source: European Medicines Agency

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

UPS' Pain in the Supply Chain Results
September 23, 2014
Merck KGaA Announces Acquisition of Sigma-Aldrich for $17 Billion
September 22, 2014
Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
Author Guidelines

Click here